A scientific assessment of VIP in experimental autoimmune encephalomyelitis (the MS model) discovered that VIP administration reduced scientific severity scores by forty–65% across 12 unbiased scientific tests, with histological Investigation exhibiting diminished CNS infiltration of Th1 and Th17 ce